These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 30337106)

  • 1. Survival Effect of Chemotherapy in Metastatic Upper Urinary Tract Urothelial Carcinoma.
    Nazzani S; Preisser F; Mazzone E; Marchioni M; Bandini M; Tian Z; Mistretta FA; Shariat SF; Soulières D; Montanari E; Acquati P; Briganti A; Carmignani L; Karakiewicz PI
    Clin Genitourin Cancer; 2019 Feb; 17(1):e97-e103. PubMed ID: 30337106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival Effect of Nephroureterectomy in Metastatic Upper Urinary Tract Urothelial Carcinoma.
    Nazzani S; Preisser F; Mazzone E; Marchioni M; Bandini M; Tian Z; Mistretta FA; Shariat SF; Soulières D; Saad F; Montanari E; Luzzago S; Briganti A; Carmignani L; Karakiewicz PI
    Clin Genitourin Cancer; 2019 Jun; 17(3):e602-e611. PubMed ID: 31005472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival effect of perioperative systemic chemotherapy on overall mortality in locally advanced and/or positive regional lymph node non-metastatic urothelial carcinoma of the upper urinary tract.
    Nazzani S; Preisser F; Mazzone E; Tian Z; Mistretta FA; Shariat SF; Soulières D; Saad F; Montanari E; Luzzago S; Briganti A; Carmignani L; Karakiewicz PI
    World J Urol; 2019 Jul; 37(7):1329-1337. PubMed ID: 30298285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increasing Rates of Perioperative Chemotherapy are Associated With Improved Survival in Men With Urothelial Bladder Cancer With Prostatic Stromal Invasion.
    Rosiello G; Knipper S; Palumbo C; Pecoraro A; Luzzago S; Deuker M; Tian Z; Gandaglia G; Gallina A; Montorsi F; Shariat SF; Saad F; Briganti A; Karakiewicz PI
    Clin Genitourin Cancer; 2020 Feb; 18(1):35-44.e1. PubMed ID: 31711842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is neoadjuvant chemotherapy for pT2 bladder cancer associated with a survival benefit in a population-based analysis?
    Mazzone E; Knipper S; Mistretta FA; Tian Z; Preisser F; Gallina A; Soulieres D; Tilki D; Montorsi F; Shariat SF; Saad F; Briganti A; Wisnivesky J; Karakiewicz PI
    Cancer Epidemiol; 2019 Feb; 58():83-88. PubMed ID: 30528834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of radical cystectomy on survival in patients with metastatic urothelial carcinoma of the urinary bladder.
    Luzzago S; Palumbo C; Rosiello G; Pecoraro A; Deuker M; Tian Z; Shariat SF; Saad F; de Cobelli O; Karakiewicz PI
    J Surg Oncol; 2019 Dec; 120(7):1266-1275. PubMed ID: 31562831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of Systemic Chemotherapy Plus Radical Nephroureterectomy for Metastatic Upper Tract Urothelial Carcinoma.
    Seisen T; Jindal T; Karabon P; Sood A; Bellmunt J; Rouprêt M; Leow JJ; Vetterlein MW; Sun M; Alanee S; Choueiri TK; Trinh QD; Menon M; Abdollah F
    Eur Urol; 2017 May; 71(5):714-718. PubMed ID: 27912971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radical cystectomy plus chemotherapy in patients with pure squamous cell bladder carcinoma: a population-based study.
    Rosiello G; Pecoraro A; Palumbo C; Knipper S; Luzzago S; Deuker M; Tian Z; Gandaglia G; Fossati N; Montorsi F; Shariat SF; Saad F; Briganti A; Karakiewicz PI
    World J Urol; 2021 Mar; 39(3):813-822. PubMed ID: 32424515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of Adjuvant Chemotherapy After Radical Nephroureterectomy for Locally Advanced and/or Positive Regional Lymph Node Upper Tract Urothelial Carcinoma.
    Seisen T; Krasnow RE; Bellmunt J; Rouprêt M; Leow JJ; Lipsitz SR; Vetterlein MW; Preston MA; Hanna N; Kibel AS; Sun M; Choueiri TK; Trinh QD; Chang SL
    J Clin Oncol; 2017 Mar; 35(8):852-860. PubMed ID: 28045620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of the ASA Physical Status Score on Adjuvant Chemotherapy Eligibility and Survival of Upper Tract Urothelial Carcinoma Patients: a Multicenter Study.
    Kang HW; Seo SP; Kim WT; Kim YJ; Yun SJ; Lee SC; Choi YD; Ha YS; Kim TH; Kwon TG; Byun SS; Jeh SU; Kim WJ
    J Korean Med Sci; 2017 Feb; 32(2):335-342. PubMed ID: 28049247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effectiveness of chemotherapy for patients with pT3N0M0 renal pelvic urothelial carcinomas: An inverse probability of treatment weighting comparison using Surveillance, Epidemiology, and End Results data.
    Liu Z; Huang J; Li X; Huang C; Ye Y; Zhang J; Liu Z
    Cancer Med; 2020 Aug; 9(16):5756-5766. PubMed ID: 32585775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of First-line Immune Checkpoint Blockade Versus Carboplatin-based Chemotherapy for Metastatic Urothelial Cancer.
    Feld E; Harton J; Meropol NJ; Adamson BJS; Cohen A; Parikh RB; Galsky MD; Narayan V; Christodouleas J; Vaughn DJ; Hubbard RA; Mamtani R
    Eur Urol; 2019 Oct; 76(4):524-532. PubMed ID: 31362898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Prognostic Impact of Histopathological Variants in Patients with Advanced Urothelial Carcinoma.
    Hsieh MC; Sung MT; Chiang PH; Huang CH; Tang Y; Su YL
    PLoS One; 2015; 10(6):e0129268. PubMed ID: 26114748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Significance of Organ-Specific Metastases in Patients with Metastatic Upper Tract Urothelial Carcinoma.
    Tufano A; Cordua N; Nardone V; Ranavolo R; Flammia RS; D'Antonio F; Borea F; Anceschi U; Leonardo C; Morrione A; Giordano A
    J Clin Med; 2022 Sep; 11(18):. PubMed ID: 36142956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Primary Tumor Location on Survival from the European Organization for the Research and Treatment of Cancer Advanced Urothelial Cancer Studies.
    Moschini M; Shariat SF; Rouprêt M; De Santis M; Bellmunt J; Sternberg CN; Tombal B; Collette L
    J Urol; 2018 May; 199(5):1149-1157. PubMed ID: 29158104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of surgery on primary site in metastatic upper urinary tract urothelial carcinoma and a nomogram for predicting the survival of patients with metastatic upper urinary tract urothelial carcinoma.
    Zhang X; Wang P; Qi K; Qiao Q; Jiang Y
    Cancer Med; 2021 Nov; 10(22):8079-8090. PubMed ID: 34647688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between comorbidities and survival in patients with metastatic urothelial carcinoma treated with pembrolizumab.
    Hashimoto M; Fukuokaya W; Yanagisawa T; Yamamoto S; Koike Y; Imai Y; Iwatani K; Onuma H; Ito K; Urabe F; Tsuzuki S; Kimura S; Oyama Y; Abe H; Miki J; Kimura T
    Int J Clin Oncol; 2024 May; 29(5):612-619. PubMed ID: 38430304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overall survival, costs, and healthcare resource use by line of therapy in Medicare patients with newly diagnosed metastatic urothelial carcinoma.
    Aly A; Johnson C; Yang S; Botteman MF; Rao S; Hussain A
    J Med Econ; 2019 Jul; 22(7):662-670. PubMed ID: 30836812
    [No Abstract]   [Full Text] [Related]  

  • 19. Prognostic model to predict survival in patients with metastatic upper tract urothelial carcinoma treated with cisplatin-based chemotherapy.
    Hsieh MC; Su YL; Chiang PH; Rau KM; Chen YY; Huang CH
    Int J Urol; 2016 May; 23(5):385-9. PubMed ID: 26992082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How do organ-specific metastases affect prognosis and surgical treatment for patients with metastatic upper tract urothelial carcinoma: first evidence from population based data.
    Dong F; Fu H; Shi X; Shen Y; Xu T; Gao F; Wang X; Zhong S; Ding Q; Shen Z; Chen S
    Clin Exp Metastasis; 2017 Dec; 34(8):467-477. PubMed ID: 29500709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.